AI-generated summary
The authors report a randomized controlled trial in mastectomized women taking hormone blockers, comparing intravascular laser irradiation of blood at 660 nm with a control group. They found no statistically significant difference in systolic or diastolic blood pressure between groups, but heart rate showed a significant difference, decreasing in the treated group. The authors conclude the therapy reduces blood pressure and heart rate, though the abstract reports the blood pressure result as not statistically significant.
- Who or what was studied
- Mastectomized women undergoing hormone blocker treatment (tamoxifen or aromatase inhibitors)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not state the total number of participants, and the blood pressure findings are not statistically significant while the conclusion claims a reduction.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.